Page last updated: 2024-10-31

neostigmine and Autoimmune Experimental Myasthenia Gravis

neostigmine has been researched along with Autoimmune Experimental Myasthenia Gravis in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research Excerpts

ExcerptRelevanceReference
"Crotamine is a basic, low-molecular-weight peptide that, at low concentrations, improves neurotransmission in isolated neuromuscular preparations by modulating sodium channels."1.39Beneficial effect of crotamine in the treatment of myasthenic rats. ( Borja-Oliveira, CR; Dal-Belo, CA; Hernandez-Oliveira e Silva, S; Randazzo-Moura, P; Rocha-e-Silva, TA; Rodrigues-Simioni, L; Rostelato-Ferreira, S; Sanchez, EF, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hernandez-Oliveira e Silva, S1
Rostelato-Ferreira, S1
Rocha-e-Silva, TA1
Randazzo-Moura, P1
Dal-Belo, CA1
Sanchez, EF1
Borja-Oliveira, CR1
Rodrigues-Simioni, L1
STUPPLER, A1

Other Studies

2 other studies available for neostigmine and Autoimmune Experimental Myasthenia Gravis

ArticleYear
Beneficial effect of crotamine in the treatment of myasthenic rats.
    Muscle & nerve, 2013, Volume: 47, Issue:4

    Topics: Animals; Cholinesterase Inhibitors; Crotalid Venoms; Drug Evaluation, Preclinical; Electromyography;

2013
[Preliminary results of experimental studies on the myasthenic syndrome].
    Klinische Wochenschrift, 1953, Feb-01, Volume: 31, Issue:5-6

    Topics: Animals; Autoimmune Diseases; Humans; Lambert-Eaton Myasthenic Syndrome; Muscular Diseases; Myasthen

1953